Wound Debridement Market Overview
The wound debridement market size was valued at $4,133.40 million in 2020 and is projected to reach $5,675.27 million by 2030, registering a CAGR of 3.2% from 2021 to 2030. Wound debridement is the medical removal of dead, damaged, infected tissue all thickened skin or callus, nonviable, and necrotic tissue to improve the healing potential of remaining tissue. In addition, the major factor that boosts the growth of the wound debridement market include increase in incidence of chronic wounds such as pressure ulcers, diabetic foot ulcers, infectious wounds, radiation wounds, arterial ulcers, and acute wound, including burn and trauma. Moreover, rise in aging population around the globe further drives the growth of the wound debridement market due to rise in number of cases of diabetic foot ulcers among the elderly.
However, high cost of advanced wound care products limits the market growth of wound debridement during the forecast period. In contrast, growth potential in emerging economies is expected to provide lucrative opportunities for wound debridement product adoption. The market is majorly driven by high incidence of diabetic foot ulcers and other target wounds, availability of reimbursement in developed economies, and rising number of burn cases.
The wound debridement market is segmented on the basis of product, wound type, method, end user, and region. By product, the market is categorized into gels, ointments & creams, surgical devices, debridement pads, and others. By wound type, it is divided into diabetic foot ulcers, pressure ulcers, surgical & trauma wounds, burns, and others. Others include infectious wounds and radiation wounds. By method, it is classified into enzymatic debridement, surgical debridement, debridement, and others. Others include autolytic & biological, By end user, the market is fragmented into hospitals, clinics, and others. Others include long-term care facilities and home healthcare.
COVID-19 Impact
Coronavirus (COVID-19) was discovered in December 2019 in Hubei province of Wuhan city in China. The disease is caused by a virus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which is transmitted from humans to humans.
After its discovery in Wuhan, the disease rapidly spread to other parts of the globe. Moreover, this virus causes various symptoms in patients, which range from common symptoms to serious symptoms. For instance, common symptoms include fever, dry cough, and fatigue. However, serious symptoms include difficulty in breathing or shortness of breath, chest pain or pressure, and loss of speech or movement. Furthermore, the virus has high potential of lethality in geriatric population. On 11th March 2020, the World Health Organization made an assessment that COVID-19 can be characterized as pandemic. In addition, there are only a few vaccines that received emergency approvals for COVID-19 treatment or prevention. Thus, social distancing is observed as the most important measure to stop the spread of this disease. Furthermore, to maintain social distancing, various countries across the world have adopted nationwide lockdowns.
Almost every nation is dealing with the outbreak. Most markets are experiencing a decline, owing to the outbreak. The COVID-19 pandemic is an unprecedented global public health challenge and the overall impact of COVID-19 pandemic remained negative for key players in the wound debridement industry. According to article published in the U.S. National Library of Medicine National Institutes of Health, 2 surveys were performed in Italy, in which the first survey was completed by 46 respondents. In this, 82.6% of cases, MD and nurses observed a decrease in patients’ appointments. In case of missed appointments, contact with the patient was not maintained in 21.7% of cases.
The most used contact method was telephone calls (58.7% of cases), with messages as the second one (43.5%). In half of the cases, MD and nurses have changed their dressing methods, by simplifying it; but only in 17.4%, they made a video to educate patients and caregivers on the proper way to wound care. The second survey was completed by 39 respondents. From their point of view, only 22.6% of cases went to the wound clinic as usual. In 59% of cases, the frequency of appointments at the clinic has drastically decreased. In case of missed appointments, 60.9% of cases did not maintain any type of contact with the specialist.
Product Segment Review
On the basis of product, the market is categorized into gels, ointments & creams, surgical devices, debridement pads, and others. The ointments & creams segment dominated the global market in 2020 and is anticipated to continue this trend during the forecast period. Rise in number of cases of acute wounds, including burn, trauma, surgical wounds, and chronic wounds, such as diabetic foot ulcer and pressure ulcer, drives the growth of this segment as ointments & creams are majorly used as a primary dressing for these wounds.
By Product
Ointments and Creams segment holds the dominant position in 2020 and would continue to maintain the lead over the forecast period.
Wound Type Segment Review
On the basis of wound type, the wound debridement market is divided into diabetic foot ulcers, pressure ulcers, surgical & trauma wounds, burns, and others. The diabetic foot ulcers segment is expected to account for the largest revenue during forecast period, owing to rise in cases of trauma across the globe. The surgical & trauma wounds segment is anticipated to witness the fastest growth rate during the forecast period, owing to increase in cases of burn injuries.
By Wound Type
Diabetic foot ulcers segment is projected as one of the most lucrative segment.
Method Segment Review
On the basis of method, the market is classified into enzymatic debridement, surgical debridement, mechanical debridement, and others. The surgical debridement segment is expected to account for the largest revenue during the forecast period, owing to rise in geriatric population, surgical wounds, and trauma wounds across the globe. The enzymatic debridement segment is anticipated to witness the fastest growth rate during the forecast period, owing to increase in cases of burn injuries.
By Method
Surgical Debridement segment holds the dominant position in 2020 and would continue to maintain the lead over the forecast period.
End User Segment Review
By end user, the market is fragmented into hospitals, clinics, and others. The hospitals segment accounted for maximum market revenue in 2020 and is anticipated to maintain its dominant position during the forecast period. This is attributed to increase in cases of diabetic foot ulcers, pressure ulcers, and surgical & trauma wounds as well as surge in surgical wound cases due to rise in number of surgeries performed in hospitals.
By End User
Hospitals segment holds the dominant position in 2020 and would continue to maintain the lead over the forecast period.
Region segment review
North America accounted for the largest share of the wound debridement market in 2020 and is expected to remain dominant during the forecast period. This is attributed to increase in sports injuries & road accidents and rise in prevalence of chronic wounds in the region, and thus escalating the demand for wound debridement products for road accidents & sports injuries. In addition, improvement in healthcare infrastructure is also anticipated to boost the market during the forecast period. The Asia-Pacific wound debridement market is expected to register significant growth rate during the forecast period, owing to increase in cases of burns, trauma as well as constantly expanding healthcare infrastructure, presence of untapped resources, economic development, and increase in number of cases of chronic diseases, especially diabetes, which are projected to drive the growth of the wound debridement market in emerging countries in Asia-Pacific.
By Region
Asia-Pacific region would exhibit the highest CAGR of 5.9% during 2021-2030
This report provides comprehensive competitive analysis and profiles of prominent market players such as Acelity L.P. Inc.; Smith & Nephew; B. Braun Melsungen AG; Coloplast A/S; ConvaTec Group; Paul Hartmann; Mölnlycke Health Care; Lohmann & Rauscher; Medline Industries; and Integra Lifesciences.
Key Benefits For Stakeholders
- This report provides a detailed quantitative analysis of the current wound debridement market trends and forecast estimations from 2020 to 2030, which assists to identify the prevailing market opportunities.
- An in-depth market analysis includes analysis of various regions, which is anticipated to provide a detailed understanding of the current trends to enable stakeholders formulate region-specific plans.
- A comprehensive analysis of factors that drive and restrain the growth of the wound debridement market is provided.
- The projections in this report are made by analyzing the current trends and future market potential from 2021 to 2030 in terms of value.
- An extensive analysis of various regions provides insights that are expected to allow companies to strategically plan their business moves.
- Key market players within the wound debridement market are profiled in this report and their strategies are analyzed thoroughly, which help in understanding competitive outlook of the wound debridement market.
Key Market Segments
By Products
- Gels
- Ointments & Creams
- Surgical Devices
- Debridement Pads
- Others
By Wound Type
- Diabetic Foot Ulcers
- Pressure Ulcers
- Surgical & Trauma Wounds
- Burns
- Others
By Method
- Enzymatic Debridement
- Surgical Debridement
- Mechanical Debridement
- Others
By End User
- Hospitals
- Clinics
- Others
By Region
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- France
- UK
- Italy
- Spain
- Rest of Europe
- Asia-Pacific
- Japan
- China
- Australia
- India
- South Korea
- Rest of Asia-Pacific
- LAMEA
- Brazil
- South Arabia
- South Africa
- Rest of LAMEA
Key Market Players
- Acelity L.P. Inc.
- Smith & Nephew
- B. Braun Melsungen AG
- Coloplast A/S
- ConvaTec Group
- Paul Hartmann
- Mölnlycke Health Care
- Lohmann & Rauscher
- Medline Industries
- Integra Lifesciences
Wound Debridement Market Report Highlights
| Aspects | Details |
 By PRODUCT |
|
 By WOUND TYPE |
|
 By METHOD |
|
 By END USER |
|
 By Region |
|
 Key Market Players | Integra Life Sciences, Paul Hartmann AG, Molnlchyke Healthcare AB, Lohmann & Rauscher, .B.Braun Melsungen AG, Convatec Group Plc., Smith & Nephew, Coloplast A/S, Medline Industries, 3 M (Acelity L.P) |
Analyst Review
Wound debridement products are the basic products intended for the management of non-severe and acute wounds. These products are generally used to clean wound, seize bleeding, hydrate wounds, close the open trauma & surgical wounds, and dry the wound to help it heal faster.
Increase in cases of patients suffering from diabetes as well as rise in prevalence of chronic wounds such as pressure ulcer, diabetic foot ulcers, venous leg ulcers, arterial ulcers; increase in number of patients undergoing surgeries; and rise in geriatric population are expected to drive the growth of the wound debridement market. Moreover, improving regulatory scenarios in developing countries are expected to provide lucrative opportunities for wound product adoption. Furthermore, surge in development and adoption of advanced wound care products may hamper the market growth of the wound debridement market during the forecast period.
The ointments & creams segment is expected to remain dominant during the forecast period, owing to increase in demand for wound debridement products due to increase in acute and chronic wounds. In addition, the acute wound segment is expected to account for the largest revenue during the forecast period, owing to growing cases of trauma globally. Moreover, North America is expected to offer lucrative opportunities to the key players during the forecast period due to growing geriatric population and rising prevalence of acute and chronic wounds along with the presence of developed infrastructure in the healthcare industry.
The total market value of wound debridement marketis $4,133.40 million in 2020.
The forcast period for wound debridement marketis 2021 to 2030
The market value of wound debridement marketin 2030 is $5,675.27 million.
The base year is 2020 in wound debridement market
Top companies such as,products B. Braun Melsungen AG, Mölnlycke Health Care AB, Smith & Nephew, 3M, Paul Hartmann, and ConvaTec Group held a high market position in 2020. These key players held a high market postion owing to the strong geographical foothold in different regions.
By product, ointments and creams segment dominated the global market in 2020 and is anticipated to continue this trend during the forecast period. The key factors such as rise in number of cases of acute wounds such as burn, trauma, surgical wounds, and chronic wounds such as diabetic foot ulcer and pressure ulcer drive the growth of this segment as ointments and creams are majorly used as a primary dressing for these wounds.
The major factor that fuels the growth of the global wound debridement market includes increase in incidence of accidents, increase in incidences of chronic diseases and surgeries drive the global wound debridement market. However, high cost of advanced wound care products is expected to hamper the market growth.
Asia-Pacific has the highest growth rate in the market which is growing due to the contribution of the emerging countries. This is due to number of factors, including increase in cases of burns, trauma, as well as constantly expanding healthcare infrastructure, the presence of untapped resources, economic development, and increase in number of cases of chronic diseases, especially diabetes, are projected to drive the growth of the wound debridement market in emerging countries in Asia-Pacific
Wound debridement contributes to the cleaning process by removing the thickened skin or callus, infected, and nonviable, necrotic, or dead tissue. It is particularly useful in the treatment of burns, trauma, and surgical wounds. Furthermore, it is also useful in treating chronic wounds such as pressure ulcers, diabetic foot ulcers, infectious wounds, radiation wounds, and arterial ulcers. These products are generally used to absorb exudate, seize bleeding, close the open trauma & surgical wounds, and dry the wound to help it heal faster
gels, ointments & creams, surgical devices, debridement pads, and others
Loading Table Of Content...
